Literature DB >> 21417752

Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care.

Earl S Ford1, Simon Capewell.   

Abstract

Mortality rates from coronary heart disease (CHD), which had risen during the twentieth century in many countries, started declining in some countries during the 1960s. Once initial skepticism about the validity of the observed trends dissipated, researchers attempted to generate explanations about the events that had transpired using a variety of techniques, including ecological examinations of the trends in risk factors for CHD and changes in management of CHD, multivariate risk equations, and increasingly sophisticated modeling techniques. Improvements in risk factors as well as changes in cardiac treatments have both contributed to the reductions in CHD mortality, although estimates of their contributions have varied among countries. Models suggest that additional large reductions in CHD mortality are feasible by either improving the distribution of risk factors in the population or raising the percentage of patients receiving evidence-based treatments.

Entities:  

Mesh:

Year:  2011        PMID: 21417752     DOI: 10.1146/annurev-publhealth-031210-101211

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  84 in total

1.  Ideal cardiovascular health and mortality from all causes and diseases of the circulatory system among adults in the United States.

Authors:  Earl S Ford; Kurt J Greenlund; Yuling Hong
Journal:  Circulation       Date:  2012-01-30       Impact factor: 29.690

Review 2.  Mitochondrial Dynamics and Heart Failure.

Authors:  A A Knowlton; T T Liu
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

3.  Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer.

Authors:  L Tong; C Ahn; E Symanski; D Lai; X L Du
Journal:  Ann Oncol       Date:  2014-03-27       Impact factor: 32.976

Review 4.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

5.  Implications of discoveries from genome-wide association studies in current cardiovascular practice.

Authors:  Panniyammakal Jeemon; Kerry Pettigrew; Christopher Sainsbury; Dorairaj Prabhakaran; Sandosh Padmanabhan
Journal:  World J Cardiol       Date:  2011-07-26

6.  Benefits gained, benefits lost: comparing baby boomers to other generations in a longitudinal cohort study of self-rated health.

Authors:  Elizabeth M Badley; Mayilee Canizares; Anthony V Perruccio; Sheilah Hogg-Johnson; Monique A M Gignac
Journal:  Milbank Q       Date:  2015-03       Impact factor: 4.911

Review 7.  Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors.

Authors:  Ram Jagannathan; Shivani A Patel; Mohammed K Ali; K M Venkat Narayan
Journal:  Curr Diab Rep       Date:  2019-06-20       Impact factor: 4.810

Review 8.  Genetics of common forms of heart failure: challenges and potential solutions.

Authors:  Christoph D Rau; Aldons J Lusis; Yibin Wang
Journal:  Curr Opin Cardiol       Date:  2015-05       Impact factor: 2.161

9.  The Contribution of Health Care and Other Interventions to Black-White Disparities in Life Expectancy, 1980-2007.

Authors:  Irma T Elo; Hiram Beltrán-Sánchez; James Macinko
Journal:  Popul Res Policy Rev       Date:  2014-02-01

10.  Systolic blood pressure response after high-intensity interval exercise is independently related to decreased small arterial elasticity in normotensive African American women.

Authors:  Stephen J Carter; TaShauna U Goldsby; Gordon Fisher; Eric P Plaisance; Barbara A Gower; Stephen P Glasser; Gary R Hunter
Journal:  Appl Physiol Nutr Metab       Date:  2016-01-07       Impact factor: 2.665

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.